Conclusion
In conclusion, human genetic variation of the CYP450 superfamily showed significant ethnic differences, mostly due to population demographic history but also due to adaptation processes. Our study pointed out three different key points. Firstly, the genetic structure of the CYP450 superfamily showed functional differences in human populations. Secondly, some CYP450 SNPs exhibited higher ethnic differences than the general distribution and these variants may be associated with a diverse predisposition to diseases or to drug response. Finally, human adaptation may have a role in the shaping the genetic variation of CYP450s.
These findings may help in understanding the role of CYP450s in health and disease in human populations and to furnish data to develop clinical strategies specific for individuals with different genetic backgrounds.
Acknowledgements
Thanks to A Novelletto (University of Rome 'Tor Vergata') for stimulating discussions on the subject. The authors are grateful to the research groups of the HapMap Consortium and of the Human Genome Diversity Project for their essential contributions.
Ethical conduct of research
The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.
Pharmacogenomics. 2012;13(16):1951-1960. © 2012 Future Medicine Ltd.